Cargando…
Biomarkers of Inflammation and Axonal Degeneration/Damage in Patients with Newly Diagnosed Multiple Sclerosis: Contributions of the Soluble CD163 CSF/Serum Ratio to a Biomarker Panel
BACKGROUND: Expression of soluble CD163 (sCD163), a macrophage/microglia biomarker, is increased in inflammatory conditions, and sCD163 levels in the cerebrospinal fluid (CSF) have recently been shown to be elevated in patients with multiple sclerosis (MS): the sCD163 CSF/serum ratio was elevated in...
Autores principales: | Stilund, Morten, Gjelstrup, Mikkel Carstensen, Petersen, Thor, Møller, Holger Jon, Rasmussen, Peter Vestergaard, Christensen, Tove |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4393241/ https://www.ncbi.nlm.nih.gov/pubmed/25860354 http://dx.doi.org/10.1371/journal.pone.0119681 |
Ejemplares similares
-
A multi‐biomarker follow‐up study of patients with multiple sclerosis
por: Stilund, Morten, et al.
Publicado: (2016) -
Soluble CD163 as a Marker of Macrophage Activity in Newly Diagnosed Patients with Multiple Sclerosis
por: Stilund, Morten, et al.
Publicado: (2014) -
Subsets of activated monocytes and markers of inflammation in incipient and progressed multiple sclerosis
por: Gjelstrup, Mikkel Carstensen, et al.
Publicado: (2017) -
Activated monocytes and markers of inflammation in newly diagnosed multiple sclerosis
por: Carstensen, Mikkel, et al.
Publicado: (2020) -
Soluble CD 163: A novel biomarker
por: Ahuja, Rajeev B.
Publicado: (2011)